• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DLK1 作为一种印记基因的上调可能与人类肝细胞癌有关。

Up-regulation of DLK1 as an imprinted gene could contribute to human hepatocellular carcinoma.

作者信息

Huang Jian, Zhang Xin, Zhang Min, Zhu Jing-De, Zhang Yun-Li, Lin Yun, Wang Ke-Sheng, Qi Xiao-Fei, Zhang Qin, Liu Guang-Zhen, Yu Jian, Cui Ying, Yang Peng-Yuan, Wang Zhi-Qin, Han Ze-Guang

机构信息

Shanghai-Ministry Key Laboratory of Disease and Health Genomics, Chinese National Human Genome Center at Shanghai, 351 Guo Shou-Jing Road, Shanghai 201203, China.

出版信息

Carcinogenesis. 2007 May;28(5):1094-103. doi: 10.1093/carcin/bgl215. Epub 2006 Nov 17.

DOI:10.1093/carcin/bgl215
PMID:17114643
Abstract

Dysregulation of a genomic imprinting gene can contribute to carcinogenesis. Here, delta-like 1 homolog (Drosophila) (DLK1), a paternally expressed gene, was found to be significantly up-regulated in 60 (73.2%) of a total of 82 hepatocellular carcinoma (HCC) specimens using reverse transcription-polymerase chain reaction. In addition, immunohistochemistry staining was performed in another 88 HCC specimens, of which 50 (56.8%) cancerous tissues were considered as positive. The expression of DLK1 was obviously induced in HCC cells, Bel-7402 and MHCC-H, by a demethylation agent, 5-aza-2'-deoxycytidine. Furthermore, both demethylation of the DLK1 promoter (-565 to -362) and hypermethylation of the imprinting control domain in the region upstream of maternally expressed gene 3 were identified in a few HCC specimens. This implies that deregulation of genomic DNA methylation of the imprinted domain could be attributed to the up-regulation of DLK1 in HCC, although the undoubtedly complex mechanisms involved in the epigenetic event should be further investigated in HCC. Surprisingly, the expression of DLK1 in HCC was confirmed to be monoallelic specific, not biallelic, in three HCC specimens with a single nucleotide polymorphism as at T852C (rs2295660). Importantly, the exogenous DLK1 can significantly promote the cell proliferation of SMMC-7721 cells, a HCC cell line, whereas the suppression of endogenetic DLK1 through RNA interference can markedly inhibit cell growth, colony formation and tumorigenicity of HepG2, Hep3B and HuH-7 cells. These data suggest that DLK1 as an imprinted gene could be significantly up-regulated in HCC due to certain epigenetic events and contribute to the oncogenesis of this tumor.

摘要

基因组印记基因的失调可能导致癌症发生。在此,使用逆转录 - 聚合酶链反应发现,父系表达基因δ样1同源物(果蝇)(DLK1)在总共82例肝细胞癌(HCC)标本中的60例(73.2%)中显著上调。此外,对另外88例HCC标本进行免疫组织化学染色,其中50例(56.8%)癌组织被认为呈阳性。去甲基化剂5 - 氮杂 - 2'-脱氧胞苷可明显诱导HCC细胞Bel - 7402和MHCC - H中DLK1的表达。此外,在一些HCC标本中鉴定出DLK1启动子(-565至-362)的去甲基化以及母系表达基因3上游区域印记控制域的高甲基化。这意味着印记域基因组DNA甲基化的失调可能是HCC中DLK1上调的原因,尽管这种表观遗传事件所涉及的无疑复杂的机制在HCC中仍需进一步研究。令人惊讶的是,在三个具有T852C(rs2295660)单核苷酸多态性的HCC标本中,HCC中DLK1的表达被证实是单等位基因特异性的,而非双等位基因。重要的是,外源性DLK1可显著促进HCC细胞系SMMC - 7721细胞的增殖,而通过RNA干扰抑制内源性DLK1可明显抑制HepG2、Hep3B和HuH - 7细胞的生长、集落形成和致瘤性。这些数据表明,作为印记基因的DLK1可能由于某些表观遗传事件在HCC中显著上调,并促进该肿瘤的发生。

相似文献

1
Up-regulation of DLK1 as an imprinted gene could contribute to human hepatocellular carcinoma.DLK1 作为一种印记基因的上调可能与人类肝细胞癌有关。
Carcinogenesis. 2007 May;28(5):1094-103. doi: 10.1093/carcin/bgl215. Epub 2006 Nov 17.
2
Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.分泌型卷曲相关蛋白1基因(SFRP1)的启动子甲基化在肝细胞癌中很常见。
Cancer. 2006 Aug 1;107(3):579-90. doi: 10.1002/cncr.22023.
3
ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis.ARHI作为一种新型的细胞生长抑制因子,在人类肝细胞癌中表达下调,可能与肝癌发生有关。
Mol Carcinog. 2009 Feb;48(2):130-40. doi: 10.1002/mc.20461.
4
Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma.印记基因DLK1是一种假定的肿瘤抑制基因,在人类肾细胞癌中,它在GTL2上游区域因表观突变而失活。
Hum Mol Genet. 2006 Mar 15;15(6):821-30. doi: 10.1093/hmg/ddl001. Epub 2006 Jan 26.
5
Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.肝细胞癌中经典 Wnt 拮抗剂分泌型卷曲相关蛋白 1 的表观遗传失活。
Neoplasma. 2012;59(3):326-32. doi: 10.4149/neo_2012_042.
6
DLK1 as a potential target against cancer stem/progenitor cells of hepatocellular carcinoma.DLK1 作为一种针对肝癌肿瘤干细胞/祖细胞的潜在靶点。
Mol Cancer Ther. 2012 Mar;11(3):629-38. doi: 10.1158/1535-7163.MCT-11-0531. Epub 2012 Jan 11.
7
Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma.作为一种假定的肿瘤抑制基因,分泌型卷曲相关蛋白1(SFRP1)的下调可能导致人类肝细胞癌。
BMC Cancer. 2007 Jul 12;7:126. doi: 10.1186/1471-2407-7-126.
8
[The imprinting status of genetic imprinted gene PEG10 in human hepatocellular carcinomas].[人类肝癌中印记基因PEG10的印记状态]
Zhonghua Gan Zang Bing Za Zhi. 2010 Dec;18(12):894-9. doi: 10.3760/cma.j.issn.1007-3418.2010.12.004.
9
Epigenetic inactivation of SLIT2 in human hepatocellular carcinomas.人肝细胞癌中SLIT2的表观遗传失活
Biochem Biophys Res Commun. 2009 Jan 30;379(1):86-91. doi: 10.1016/j.bbrc.2008.12.022. Epub 2008 Dec 17.
10
Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.活性氧诱导的肝细胞癌表观遗传变化:E-钙黏蛋白启动子的甲基化
Gastroenterology. 2008 Dec;135(6):2128-40, 2140.e1-8. doi: 10.1053/j.gastro.2008.07.027. Epub 2008 Jul 31.

引用本文的文献

1
Inhibition of DLK1 regulates AT2 differentiation and alleviates established pulmonary fibrosis by upregulating TTF-1/CLDN6.抑制DLK1可通过上调TTF-1/CLDN6来调节II型肺泡上皮细胞(AT2)分化并减轻已形成的肺纤维化。
Respir Res. 2025 May 16;26(1):188. doi: 10.1186/s12931-025-03264-z.
2
Titration of RAS alters senescent state and influences tumour initiation.RAS 滴定改变衰老状态并影响肿瘤起始。
Nature. 2024 Sep;633(8030):678-685. doi: 10.1038/s41586-024-07797-z. Epub 2024 Aug 7.
3
DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis.
β-连环蛋白依赖性增强子上调 DLK1/DIO3 基因座驱动细胞增殖和肝肿瘤发生。
Mol Ther. 2024 Apr 3;32(4):1125-1143. doi: 10.1016/j.ymthe.2024.01.036. Epub 2024 Feb 3.
4
LncTUG1 contributes to the progression of hepatocellular carcinoma via the miR-144-3p/RRAGD axis and mTOR/S6K pathway.LncTUG1 通过 miR-144-3p/RRAGD 轴和 mTOR/S6K 途径促进肝细胞癌的进展。
Sci Rep. 2023 May 9;13(1):7500. doi: 10.1038/s41598-023-33976-5.
5
Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update.肝细胞癌-胆管癌合并症的病理学:最新进展
Cancers (Basel). 2023 Jan 13;15(2):494. doi: 10.3390/cancers15020494.
6
Pituitary Tumor-Transforming Gene 1/Delta like Non-Canonical Notch Ligand 1 Signaling in Chronic Liver Diseases.垂体肿瘤转化基因 1/Delta 样非经典 Notch 配体 1 在慢性肝病中的信号转导。
Int J Mol Sci. 2022 Jun 21;23(13):6897. doi: 10.3390/ijms23136897.
7
The pituitary tumour-transforming gene 1/delta-like homologue 1 pathway plays a key role in liver fibrogenesis.垂体瘤转化基因 1/Delta 样同源物 1 通路在肝纤维化中起关键作用。
Liver Int. 2022 Mar;42(3):651-662. doi: 10.1111/liv.15165. Epub 2022 Jan 30.
8
Emerging Roles of DLK1 in the Stem Cell Niche and Cancer Stemness.DLK1 在干细胞生态位和癌症干性中的新兴作用。
J Histochem Cytochem. 2022 Jan;70(1):17-28. doi: 10.1369/00221554211048951. Epub 2021 Oct 4.
9
Transcriptome sequencing-based personalized analysis of hepatocellular carcinoma patients with portal vein tumor thrombus.基于转录组测序的门静脉癌栓肝细胞癌患者个性化分析
J Gastrointest Oncol. 2021 Apr;12(2):795-805. doi: 10.21037/jgo-21-162.
10
Adenomatous polyposis coli-binding protein end-binding 1 promotes hepatocellular carcinoma growth and metastasis.腺瘤性结肠息肉病结合蛋白末端结合蛋白 1 促进肝癌生长和转移。
PLoS One. 2020 Sep 21;15(9):e0239462. doi: 10.1371/journal.pone.0239462. eCollection 2020.